Tesamorelin
A stabilized GHRH analog studied in growth-hormone-axis research.
Overview
Tesamorelin is a synthetic analog of growth-hormone-releasing hormone (GHRH). In research literature it is studied for its interactions with the growth-hormone axis and related metabolic pathways. It is one of the more extensively characterized GHRH-analog peptides in the research category.
Referenced research ranges
1–2 mg, once daily — commonly referenced before bed in the literature
Reconstitution default
5 mg in 2 mL yields 2.5 mg/mL; a 1 mg reference dose is 0.4 mL (40 units on a U-100 syringe).
Storage
Store lyophilized vials refrigerated where possible; refrigerate after reconstitution and use within the research-standard window.
Considerations
- Short circulating half-life, so research protocols reference daily administration.
- Frequently studied together with a secretagogue such as Ipamorelin in the literature.
- Reconstituted peptide is temperature-sensitive and light-sensitive.
Log doses, get reminders, and run the calculator in PepSensei.
PepSensei is an educational reference tool only. Nothing in this library is medical advice, and none of it is intended to diagnose, treat, cure, or prevent any condition. All figures — including dose ranges, half-lives, and reconstitution examples — are commonly-cited values drawn from published research literature and are provided strictly for reference and general education in a research context. They are not protocols, recommendations, or instructions. Always consult a licensed medical professional before making any decision related to your health.